These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2472897)

  • 21. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koula-Shiro S
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled study on progressive primary pulmonary tuberculosis in children treated for one year with dual drugs: streptomycin and isoniazid versus isoniazid and thiacetazone.
    Gupta SK; Law SC
    J Indian Med Assoc; 1972 Dec; 59(11):463-7. PubMed ID: 4120719
    [No Abstract]   [Full Text] [Related]  

  • 24. Pattern of some haematological indices in newly diagnosed pulmonary tuberculosis cases in Iwo, Nigeria: diagnostic and therapeutic implications.
    Dosumu EA
    Niger J Med; 2001; 10(1):18-20. PubMed ID: 11705048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 27. Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen.
    Van Deun A; Aung KJ; Hamid Salim MA; Ali MA; Naha MS; Das PK; Hossain MA; Declercq E
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1255-61. PubMed ID: 17131785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thiacetazone toxicity trial in Sarawak.
    Webb AH
    N Z Med J; 1973 Nov; 78(502):490-12. PubMed ID: 4129254
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinical trial of thiacetazone-INH combination in pulmonary tuberculosis in children.
    Krishnamurthy KA; Subramanian J
    Indian Pediatr; 1968 Aug; 5(8):379-81. PubMed ID: 4182459
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative trials of 3 ambulatory therapeutic methods for pulmonary tuberculosis in Senegal. (Preliminary results of TB1)].
    Rabier M; Sarrat H
    Rev Tuberc Pneumol (Paris); 1971 Nov; 35(7):751-62. PubMed ID: 4114357
    [No Abstract]   [Full Text] [Related]  

  • 32. Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases.
    Wirima JJ; Harries AD
    East Afr Med J; 1991 Jan; 68(1):64-6. PubMed ID: 2060484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of acute progressive tuberculosis types].
    Khomenko AG; Mishin VI
    Probl Tuberk; 1996; (5):21-3. PubMed ID: 8984482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of cytomorphology of tuberculous lymphadenitis and changes during anti-tubercular treatment.
    Sharma M; Agarwal S; Wadhwa N; Mishra K; Gadre DJ
    Cytopathology; 2007 Jun; 18(3):180-3. PubMed ID: 17388932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. A. General report.
    Bignall JR
    Bull Int Union Tuberc; 1970 Aug; 44():8-37. PubMed ID: 4195346
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The outcome of tuberculosis in patients on chronic hemodialysis.
    Taskapan H; Utas C; Oymak FS; Gülmez I; Ozesmi M
    Clin Nephrol; 2000 Aug; 54(2):134-7. PubMed ID: 10968689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV; Mordyk AV; Zatvornitskiĭ VA; Kondria AV
    Probl Tuberk Bolezn Legk; 2006; (9):45-8. PubMed ID: 17128801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.